US 7358360
Risedronate sodium having a very low content of iron
granted A61PA61P19/08A61P19/10
Quick answer
US patent 7358360 (Risedronate sodium having a very low content of iron) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P19/08, A61P19/10, A61P9/10